Abstract
Objective: To discuss the diagnostic potential of salivary biomarkers in oral squamous cell carcinoma, considering their ability to distinguish it from oral potentially malignant disorders and the limitations affecting clinical application. Literature review: Saliva is an accessible, noninvasive source of components related to the tumor microenvironment. Cytokines, matrix metalloproteinases, cell-free DNA, microRNAs, exosomes, proteins, autoantibodies, and metabolites show alterations associated with carcinoma. MMP-9, salivary cell-free DNA integrity, and selected microRNAs have yielded promising findings, while multibiomarker panels have generally performed better than isolated molecules. However, heterogeneous protocols, small samples, the influence of oral inflammatory conditions, and limited external validation hinder comparison across studies and clinical implementation. Final considerations: Salivary biomarkers show potential as complementary tools for screening and diagnostic support, but they do not replace clinical assessment or histopathological confirmation. Prospective, multicenter, standardized studies are required to validate their applicability across independent populations and healthcare settings before routine clinical use.
References
AHMED AA, et al. Mutation detection in saliva from oral cancer patients. Oral Oncology, 2024; 151: 106717.
BALAKITTNEN J, et al. A novel saliva-based miRNA profile to diagnose and predict oral cancer. International Journal of Oral Science, 2024; 16(1): 14.
BENITO-RAMAL E, et al. Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma: a systematic review and meta-analysis. Medicina Oral, Patología Oral y Cirugía Bucal, 2023; 28(5): e474–e486.
BRAY F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians, 2024; 74(3): 229–263.
CAI M, et al. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers. BMC Cancer, 2022; 22(1): 530.
CHAMOLI A, et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncology, 2021; 121: 105451.
CRUZ-ROMERO SD, et al. Saliva liquid biopsy: MMP2, MMP9, and TIMP2 as potential diagnostic biomarkers in oral squamous cell carcinoma: an observational case-control study. Journal of Applied Oral Science, 2026; 34: e20250555.
ESPEROUZ F, et al. Saliva-based biomarkers in oral squamous cell carcinoma using OMICS technologies: A systematic review. Oral, 2024; 4(3): 293–302.
GARG A, et al. Evaluation of diagnostic significance of salivary miRNA-184 and miRNA-21 in oral squamous cell carcinoma and oral potentially malignant disorders. Head and Neck Pathology, 2023; 17(4): 961–968.
GONZÁLEZ-RUIZ I, et al. Early diagnosis of oral cancer: A complex polyhedral problem with a difficult solution. Cancers, 2023; 15: 3270.
HSIEH YJ, et al. Systematic verification of saliva-based biosignatures for oral cancer via targeted metabolomics. Journal of Food and Drug Analysis, 2026; 34(1): 88–103.
HSUEH PC, et al. Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma. Frontiers in Oncology, 2022; 12: 968570.
HU CC, et al. Emerging salivary biomarkers for early detection of oral squamous cell carcinoma. World Journal of Clinical Oncology, 2025; 16(4): 103803.
HUANG L, et al. The relationship between salivary cytokines and oral cancer and their diagnostic capability for oral cancer: a systematic review and network meta-analysis. BMC Oral Health, 2024; 24(1): 1044.
JAIN A, et al. Identification of potential salivary biomarker panels for oral squamous cell carcinoma. Scientific Reports, 2021; 11(1): 3365.
KHIJMATGAR S, et al. Salivary biomarkers for early detection of oral squamous cell carcinoma and head and neck squamous cell carcinoma: a systematic review and network meta-analysis. Japanese Dental Science Review, 2024; 60: 32–39.
KUMAR SK, et al. Evaluation of salivary and serum exosomal mRNAs as biomarkers for the diagnosis and prognosis of oral squamous cell carcinoma. Scientific Reports, 2025; 15(1): 38310.
KUMARI P, et al. Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma. Journal of Taibah University Medical Sciences, 2021; 16(5): 733–739.
LARONHA H, CALDEIRA J. Structure and function of human matrix metalloproteinases. Cells, 2020; 9(5): 1076.
LIU Y, et al. Metabolic and microbial alterations in oral potentially malignant disorders versus oral squamous cell carcinoma. Scientific Reports, 2025; 15(1): 40637.
MA L, et al. Liquid biopsy in cancer: Current status, challenges and future prospects. Signal Transduction and Targeted Therapy, 2024; 9(1): 336.
MAURYA S, et al. Matrix metalloproteinases in oral cancer pathogenesis and their use in therapy. Anti-Cancer Agents in Medicinal Chemistry, 2024; 24(1): 3–17.
MEHTEROV N, et al. Salivary miR-30c-5p as potential biomarker for detection of oral squamous cell carcinoma. Biomedicines, 2021; 9(9): 1079.
NAITO Y, HONDA K. Liquid biopsy for oral cancer diagnosis: Recent advances and challenges. Journal of Personalized Medicine, 2023; 13: 303.
NIEKRA P, ADAMSKA P. The role of liquid biopsy in the diagnosis of oral squamous cell carcinoma: A systematic review. International Journal of Molecular Sciences, 2026; 27(2): 677.
NONAKA T, WONG DTW. Saliva diagnostics: Salivaomics, saliva exosomics, and saliva liquid biopsy. Journal of the American Dental Association, 2023; 154(8): 696–704.
PANNEERSELVAM K, et al. Salivary monoacetylated polyamines as noninvasive biomarkers for early detection and stratification of oral squamous cell carcinoma: a targeted metabolomics study. Archives of Oral Biology, 2026; 184: 106513.
QIE Y, et al. Emerging functions and applications of exosomes in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, 2023; 52(10): 886–894.
RANI NAJ, et al. Evaluation of salivary interleukin-6 in patients with oral squamous cell carcinoma, oral potentially malignant disorders, chronic periodontitis and in healthy controls: a cross-sectional comparative study. Annals of Maxillofacial Surgery, 2023; 13(1): 70–75.
RAPADO-GONZÁLEZ Ó, et al. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: a preliminary study. Journal of Oral Pathology & Medicine, 2022; 51(5): 429–435.
ROCCHETTI F, et al. Expression analysis of circulating microRNAs in saliva and plasma for the identification of clinically relevant biomarkers for oral squamous cell carcinoma and oral potentially malignant disorders. Cancers, 2024; 16(17): 2990.
RUMGAY H, et al. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. CA Cancer Journal for Clinicians, 2026; 76(1).
SCHOLTZ B, et al. Salivary miR-31-5p, miR-345-3p, and miR-424-3p are reliable biomarkers in patients with oral squamous cell carcinoma. Pathogens, 2022; 11(2): 229.
SHI S, et al. The roles of exosomes in the diagnosis, development and therapeutic resistance of oral squamous cell carcinoma. International Journal of Molecular Sciences, 2023; 24: 1968.
SUN H, et al. Global burden of head and neck cancer: Epidemiological transitions, inequities, and projections to 2050. Frontiers in Oncology, 2025; 15: 1665019.
TAN Y, et al. Oral squamous cell carcinomas: State of the field and emerging directions. International Journal of Oral Science, 2023; 15: 44.
UCHIDA H, OVITT CE. Novel impacts of saliva with regard to oral health. Journal of Prosthetic Dentistry, 2022; 127(3): 383–391.
VATS R, et al. Salivary biomarkers in non-invasive oral cancer diagnostics: A comprehensive review. Journal of Applied Oral Science, 2024; 32: e20240151.
VIMAL J, et al. Identification of salivary metabolic biomarker signatures for oral tongue squamous cell carcinoma. Archives of Oral Biology, 2023; 155: 105780.
WANG S, et al. Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: A review. European Journal of Medical Research, 2023; 28: 53.
ZHAO B, LI Z, LI R. Exosomes in oral squamous cell carcinoma: functions, challenges, and potential applications. Front Oncol. 2025 Jan 16;14:1502283.
